000 | 01540 a2200421 4500 | ||
---|---|---|---|
005 | 20250515232940.0 | ||
264 | 0 | _c20100824 | |
008 | 201008s 0 0 eng d | ||
022 | _a1791-7530 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBlock, Martin | |
245 | 0 | 0 |
_aAntiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells. _h[electronic resource] |
260 |
_bAnticancer research _cJun 2010 |
||
300 |
_a2025-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aAromatase _xanalysis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aEndometrial Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aEstrogen Antagonists _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPTEN Phosphohydrolase _xanalysis |
650 | 0 | 4 |
_aPhosphorylcholine _xanalogs & derivatives |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xanalysis |
650 | 0 | 4 | _aReceptors, Estrogen |
650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xanalysis |
650 | 0 | 4 |
_aReceptors, Growth Factor _xantagonists & inhibitors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTamoxifen _xanalogs & derivatives |
700 | 1 | _aFister, Stefanie | |
700 | 1 | _aEmons, Günter | |
700 | 1 | _aSeeber, Sandrine | |
700 | 1 | _aGründker, Carsten | |
700 | 1 | _aGünthert, Andreas R | |
773 | 0 |
_tAnticancer research _gvol. 30 _gno. 6 _gp. 2025-31 |
|
999 |
_c19992032 _d19992032 |